CP
LLY icon

Corbenic Partners’s Eli Lilly LLY Stock Holding History

Corbenic Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$6K Hold
20
– – ﹤0.01% 152
2022
Q1 		$6K Buy
20
+10
+100% +$2.57K ﹤0.01% 174
2021
Q4 		$3K Hold
10
– – ﹤0.01% 239
2021
Q3 		$2K Buy
+10
New +$2.47K ﹤0.01% 253
2017
Q2 		– Sell
-105
Closed -$17K – 186
2017
Q1 		$17K Hold
105
– – 0.02% 107
2016
Q4 		$16K Hold
105
– – 0.02% 112
2016
Q3 		$16K Sell
105
-95
-48% -$7.6K 0.02% 105
2016
Q2 		$16K Buy
+200
New +$15.1K 0.02% 104

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Corbenic Partners's LLY Position: Q2 2022 in Review

Corbenic Partners held its Eli Lilly (LLY) position steady in Q2 2022 at 20 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #152.

Corbenic Partners first reported a position in LLY in Q2 2016 and has held it in 8 quarters since. The position peaked at $17K in Q1 2017. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

  • Corbenic Partners held 20 shares of Eli Lilly worth $6K as of Q2 2022.
  • Corbenic Partners left its Eli Lilly share count unchanged in Q2 2022.
  • Eli Lilly made up ﹤0.01% of Corbenic Partners's portfolio in Q2 2022, its #152 holding.
  • Corbenic Partners first reported a position in Eli Lilly in Q2 2016 and has held it in 8 quarters since.
  • Corbenic Partners's Eli Lilly position peaked at $17K in Q1 2017.
  • 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on Corbenic Partners's 13F filing for Q2 2022, filed 25 Jul 2022.